Glomus Jugulare: Expert Skull Base Surgery at AF Medico Belgrade
- 3 days ago
- 5 min read
A Complex Glomus Jugulare Case — And What It Tells Us About Skull Base Surgery
At AF Medico Belgrade, Prof. Dr. Andrew J. Fishman recently led the surgical team in the removal of a giant glomus jugulare — a rare and complex paraganglioma of the skull base. The tumor had previously been treated with radiation therapy at another center, an approach that proved unsuccessful and was associated with progressive facial nerve paralysis. Through advanced intraoperative nerve monitoring and meticulous microsurgical technique, Prof. Dr. Fishman and his team successfully achieved complete tumor removal while preserving the function of all remaining cranial nerves. A facial nerve graft was also performed as part of the reconstructive plan to support facial movement recovery in this young patient.
What Is a Glomus Jugulare?
A **glomus jugulare** is a rare, slow-growing paraganglioma — a benign but locally aggressive tumor — that arises from paraganglionic tissue near the jugular bulb at the base of the skull. Because of its location, the tumor can encroach upon critical structures including the internal carotid artery, the internal jugular vein, and multiple cranial nerves (VII, IX, X, XI, and XII).
Glomus jugulare tumors are among the most technically demanding lesions in all of neurotology and cranial base surgery. They may cause:
- Progressive hearing loss or pulsatile tinnitus
- Facial weakness or palsy (cranial nerve VII involvement)
- Difficulty swallowing or hoarseness (cranial nerves IX and X)
- Shoulder weakness (cranial nerve XI)
- Tongue weakness or atrophy (cranial nerve XII)
Because of their proximity to vital neurovascular structures, these tumors require a surgeon with subspecialty training in both **neurotology** and **skull base surgery** — exactly the expertise Prof. Dr. Andrew J. Fishman brings to every case at AF Medico Belgrade.
Who May Be a Candidate for Glomus Jugulare Surgery?
Prof. Dr. Fishman evaluates each patient individually, taking into account tumor size, extent of involvement, prior treatments, overall health, and functional status of affected cranial nerves. In appropriate candidates, surgical intervention may be considered when:
- The tumor is causing progressive neurological symptoms
- Radiation therapy has failed or is contraindicated
- The tumor has significantly grown on serial imaging
- The patient is medically fit to undergo skull base surgery
- Hearing preservation or facial nerve rehabilitation is a surgical goal
Patients who have undergone prior radiation — as in the case described above — present particular challenges, including altered tissue planes and increased operative complexity. Prof. Dr. Fishman specializes in revision skull base surgery and re-operative cases where initial treatment at other institutions has been unsuccessful.
The Surgical Procedure: What to Expect
Surgical removal of a glomus jugulare at AF Medico Belgrade follows a structured, internationally standardized protocol:
- **Preoperative imaging and planning:** High-resolution MRI and CT angiography are used to map tumor extent and vascular supply. Preoperative embolization may be performed to reduce intraoperative bleeding.
- **Anesthesia and positioning:** The procedure is performed under general anesthesia, typically lasting **6–12 hours** depending on tumor complexity.
- **Surgical approach:** Prof. Dr. Fishman uses the infratemporal fossa approach (Type A or modified variants), a technique requiring subspecialty neurotological training.
- **Intraoperative nerve monitoring:** Continuous electromyographic monitoring of all at-risk cranial nerves is employed throughout the procedure to maximize preservation of neurological function.
- **Tumor removal:** Microsurgical dissection allows complete or near-complete tumor excision in appropriate candidates.
- **Reconstruction:** Where cranial nerve injury has occurred — whether from the tumor itself or from prior treatments such as radiation — nerve grafting procedures may be performed. In the case described, a facial nerve graft was carried out as part of a staged reconstructive plan.
Recovery and Follow-Up
Recovery following glomus jugulare surgery depends on tumor size, the extent of resection, and the degree of cranial nerve involvement. Patients may expect:
- **Hospital stay:** Typically **5–10 days** for complex skull base cases
- **Initial recovery period:** Approximately **4–6 weeks** before returning to light activity
- **Cranial nerve rehabilitation:** Patients with facial nerve involvement may benefit from structured facial physiotherapy and, where appropriate, staged surgical rehabilitation of facial movement
- **Long-term follow-up:** Serial MRI imaging is recommended to monitor for tumor recurrence, particularly in cases managed with subtotal resection or post-radiation revision surgery
Prof. Dr. Fishman works with a multidisciplinary team — including neurologists, radiologists, and rehabilitation specialists — to coordinate each patient's individualized care plan.
Why Choose Prof. Dr. Andrew J. Fishman at AF Medico Belgrade?
Prof. Dr. Andrew J. Fishman is an internationally trained otologist, neurotologist, and cranial base surgeon practicing at AF Medico Beograd in Belgrade, Serbia. His clinical focus encompasses the full spectrum of skull base pathology, including:
- **Glomus jugulare and paraganglioma surgery**
- Acoustic neuroma (vestibular schwannoma) removal
- Cochlear implant surgery for hearing restoration
- Facial nerve rehabilitation and reanimation
- Cholesteatoma and chronic ear disease surgery
Patients travel from across Europe and internationally to AF Medico Belgrade to benefit from Prof. Dr. Fishman's subspecialty expertise — particularly in complex, revision, or previously treated cases where standard approaches have failed.
AF Medico Belgrade combines international-standard surgical technology — including intraoperative neurophysiological monitoring, advanced microsurgical instruments, and high-resolution intraoperative imaging — with personalized, patient-centered care.
Frequently Asked Questions About Glomus Jugulare
Q1: Is a glomus jugulare tumor cancerous?
A glomus jugulare is typically a **benign paraganglioma**, meaning it does not spread to distant organs the way malignant cancers do. However, it is considered locally aggressive — it can erode bone, compress cranial nerves, and invade critical vascular structures. Malignant variants exist but are rare. Prof. Dr. Fishman evaluates each case individually with full histopathological and imaging review.
Q2: Can a glomus jugulare be treated with radiation alone?
Radiation therapy — including stereotactic radiosurgery — may be used as a primary treatment or as an adjunct to surgery in selected cases. However, as illustrated in a recent case at AF Medico Belgrade, radiation does not always result in tumor control and may be associated with progressive cranial nerve deficits. Prof. Dr. Fishman specializes in the management of patients where prior radiation has failed, offering surgical options that may still be appropriate in carefully selected individuals.
Q3: What is facial nerve grafting, and will it restore movement?
Facial nerve grafting is a reconstructive microsurgical technique in which a segment of donor nerve (often the great auricular nerve or sural nerve) is used to bridge a gap in the injured facial nerve. In appropriate candidates, nerve grafting may support the recovery of facial movement over time — typically over a period of **12–24 months** as nerve regeneration progresses. Prof. Dr. Fishman may also recommend staged surgical procedures to further optimize facial reanimation outcomes.
Q4: How long does recovery from glomus jugulare surgery take?
Full recovery is a gradual process and varies by case complexity. Most patients are discharged within **5–10 days** of surgery. Light activity may resume after **4–6 weeks**, while complete neurological recovery — particularly involving cranial nerves — may continue for **12–24 months** or longer. Prof. Dr. Fishman provides individualized recovery timelines during the consultation and follow-up process.
Q5: Does AF Medico Belgrade accept international patients?
Yes. AF Medico Belgrade regularly treats patients from across Europe, the Middle East, and beyond. Prof. Dr. Fishman's team can assist with consultation scheduling, medical record review, and coordination of travel and accommodation for international patients seeking skull base surgery in Serbia.
